Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196

Watchlist Manager
Shanghai Fosun Pharmaceutical Group Co Ltd Logo
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Watchlist
Price: 23.1 CNY -0.43%
Updated: May 27, 2024
Shanghai Fosun Pharmaceutical Group Co Ltd
/
Income Statement
/
Operating Income

Shanghai Fosun Pharmaceutical Group Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Fosun Pharmaceutical Group Co Ltd
Operating Income Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Operating Income
¥1.1B
CAGR 3-Years
-26%
CAGR 5-Years
-13%
CAGR 10-Years
-3%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥2.6B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.5B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥4.8B
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
12%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.9B
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
4%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Operating Income
-¥749.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Operating Income?
Operating Income
1.1B CNY

Based on the financial report for Mar 31, 2024, Shanghai Fosun Pharmaceutical Group Co Ltd's Operating Income amounts to 1.1B CNY.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-3%

Over the last year, the Operating Income growth was -68%. The average annual Operating Income growth rates for Shanghai Fosun Pharmaceutical Group Co Ltd have been -26% over the past three years , -13% over the past five years , and -3% over the past ten years .

ALPHA SPREAD
Join more than 141,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.